Tulsa County Jail Eradicates Long-Standing Staph Problem: No New Cases in 5 Months With Use of Staph Attack Disinfectant
08 Febrero 2007 - 7:00AM
PR Newswire (US)
Product Now in Use in 14 Additional Correctional Facilities TULSA,
Okla., Feb. 8 /PRNewswire-FirstCall/ -- Enviroguard Technologies,
LLC, distributors of Staph Attack(TM), a new hard surface
disinfectant containing PURE Bioscience's (OTC:PURE) (BULLETIN
BOARD: PURE) patented silver dihydrogen citrate, announced reports
of outstanding success with the surface disinfectant that kills
resistant forms of Staph. Tulsa County Jail reports that since the
introduction of the product in August of last year, the jail has
completely eliminated Staph infections, including MRSA, a resistant
form of Staph. (Logo:
http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO ) The
jail, with its 1700 cells and more than 1500 inmates, had
historically faced challenges with a resistant form of Staph known
as Methicillin-resistant Staphylococcus Aureus (MRSA). Prior to use
of the new disinfectant, the facility experienced, on average, 12
cases of Staph infection every month. According to Tulsa County
Sheriff, Stanley Glanz, "We have been using Staph Attack for five
months and have eliminated the reoccurrence of Staph infections in
the facility. We are pleased to have created a healthier
environment and at the same time save money." As part of its
regular cleaning and maintenance program, the jail now uses Staph
Attack to disinfect booking areas, bathrooms, counter tops, cells
and mattresses. Using Staph Attack has provided time and cost
savings: The 24 hour residual protection offered by the product,
combined with the lowest possible level of toxicity as defined by
the EPA, means less frequent applications and no need for
protective wear such as gloves and masks. Staph Attack is presently
being used in 15 different correctional facilities in 9 states,
including Oklahoma, Kansas, Tennessee, Ohio, Minnesota, Louisiana,
Pennsylvania, Florida and Texas. Staph Attack is the silver-based
hard surface disinfectant created by PURE Bioscience and
distributed by Enviroguard Technologies specifically for closed
populations where resistant bacteria are becoming increasingly
problematic, such as hospitals, prisons and schools. Staph Attack
carries EPA-registered claims against Methicillin-resistant
Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus
faecium (VRE), while maintaining the Category IV lowest-toxicity
EPA rating. It kills the potentially deadly bacteria in just two
minutes' time and does not require rinsing. How does it work?
Silver dihydrogen citrate (SDC), is an electrolytically generated
source of stabilized ionic silver. In one of the mechanisms of
action, the bacteria views the molecule as a food source, and once
the organism consumes it, SDC destroys the bacteria by disabling
proteins and halting its metabolic and reproductive functions. SDC
is colorless, odorless, tasteless, non-caustic and formulates well
with other compounds. As a platform technology, SDC is
distinguished from competitors in the marketplace because of its
superior efficacy, reduced toxicity and the inability of bacteria
to form a resistance to it. About Enviroguard Technologies, LLC
EnviroGuard Technologies is a privately held company dedicated to
offering new environmentally safe products with high efficacy to
institutional, industrial, commercial and retail consumers. One
such product line, powered by SDC (silver dihydrogen citrate), is a
proprietary product of PURE Bioscience. The first product is Staph
Attack, a hard surface disinfectant highly effective against broad
spectrum bacteria including resistant staph bacteria such as MRSA
and VRE. EnviroGuard Technologies is headquartered in Tulsa,
Oklahoma. For additional information visit the Company's website:
http://www.enviroguardtech.net/ . About PURE Bioscience PURE
Bioscience (PURE) develops and markets technology-based bioscience
products that provide solutions to numerous global health
challenges. PURE's proprietary high efficacy/low toxicity
bioscience technologies, including its silver dihydrogen
citrate-based antimicrobials, represent innovative advances in
diverse markets and lead today's global trend toward industry and
consumer use of "green" products while providing competitive
advantages in efficacy and safety. PURE Bioscience, headquartered
in El Cajon, California, (San Diego metropolitan area), was
incorporated in 1992. For additional information on PURE
Bioscience, visit the Company's website: http://www.purebio.com/ .
This press release includes statements that may constitute
"forward- looking" statements, usually containing the words
"believe", "estimate", "project", "expect" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. Factors that would cause or
contribute to such differences include, but are not limited to,
acceptance of the Company's current and future products and
services in the marketplace, the ability of the Company to develop
effective new products and receive regulatory approvals of such
products, competitive factors, dependence upon third-party vendors,
and other risks detailed in the Company's periodic report filings
with the Securities and Exchange Commission. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this release. Company Contact: Media Contact: Shawn LeBar Karen
Sparks Enviroguard Technologies Mentus 918-398-6395 858-455-5500
x275 http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO
http://photoarchive.ap.org/ DATASOURCE: PURE Bioscience CONTACT:
Shawn LeBar, Enviroguard Technologies, +1-918-398-6395, ; media,
Karen Sparks, Mentus, +1-858-455-5500 x275, Web site:
http://www.purebio.com/ http://www.enviroguardtech.net/
Copyright